Anheuser-Busch InBev is the largest brewer in the world and one of the world's top five consumer product companies, as measured by EBITDA... Show more
In recent trading sessions, Anheuser-Busch InBev (BUD) stock has demonstrated upward momentum, outperforming broader consumer staples peers year-to-date. The shares have benefited from resilient demand for premium brands like Budweiser and Stella Artois, alongside proactive investments in manufacturing capacity. Trading near the upper end of its 52-week range, BUD reflects investor confidence in the company's pricing power and portfolio optimization efforts. While macroeconomic pressures like currency fluctuations linger, positive sentiment around operational expansions and marketing initiatives has supported steady gains in the latest market cycle. Analysts maintain an outperform rating, underscoring BUD's defensive qualities in a volatile environment.
Tickeron's Trending AI Robots page showcases the top 25 performers selected from over 350 AI trading bots that collectively trade thousands of tickers across diverse sectors. These curated bots stand out for their adaptability to current market conditions, delivering impressive paper trading results such as annualized returns ranging from 23% to over 160%, win rates between 51% and 88%, and profit factors up to 11.7. Trading styles vary widely, including trend-following, swing trading, and multi-agent strategies across timeframes like 5-minute to 49-day holds, with assets spanning stocks, leveraged ETFs, and more. While none currently focus solely on beverages, the platform's extensive library ensures options for consumer staples exposure. Explore these high-performing bots for potential copy-trading opportunities tailored to today's volatility.
Anheuser-Busch InBev (BUD) has seen its stock rise approximately 8% from early April lows around $70, crossing above the 50-day moving average late last month, as anticipation builds for Q1 2026 earnings due May 5. Wall Street expects EPS of $0.90, a 11.1% year-over-year increase, fueled by revenue growth from premium brands and effective pricing strategies, though headwinds in China and foreign exchange (FX) volatility temper some optimism.
Key catalysts include a major U.S. manufacturing expansion, with investments rising to $600 million to enhance production capacity. This initiative pairs with new training programs and veteran hiring efforts, signaling commitment to domestic operations and supply chain resilience. These moves have reassured investors amid ongoing cost pressures in the industry.
Marketing momentum accelerated with Budweiser's high-profile partnership featuring soccer stars Erling Haaland and Jürgen Klopp for the "Let it Pour" FIFA World Cup 2026™ campaign. This ties into broader premiumization efforts, where megabrands drive revenue, contributing to BUD's 24% gain over the past six months versus the industry's 12.5%.
The April 29 shareholder meeting approved a €1.15 gross dividend for 2025 (ex-date May 8) and refreshed the board, reinforcing governance stability. Non-alcoholic offerings, particularly Zero products, are gaining share as consumers shift toward low- and no-alcohol options, supporting volume recovery.
Analyst actions remain supportive, with consensus targets averaging $87.89 (high $100), and recent maintains at outperform. Options activity hints at expected volatility around earnings. Collectively, these factors have shifted sentiment positively, linking operational wins to price appreciation without major disruptions.
Anheuser-Busch InBev's 2026 guidance targets 4-8% organic EBITDA (earnings before interest, taxes, depreciation, and amortization) growth, consistent with medium-term ambitions, bolstered by mega-brand performance and events like FIFA World Cup 2026 sponsorships. Investors should track premiumization progress, with premium brands expected to outpace total revenue, alongside non-alcoholic expansion amid health trends. Emerging markets could deliver 6-9% CAGR through 2028 via distribution enhancements and capacity investments.
U.S. manufacturing scaling to $600 million supports efficiency, but rising input costs and debt levels (targeting 2-2.5x net debt-to-EBITDA) warrant scrutiny. Supply chain digitization and route-to-market optimizations offer efficiency gains. Risks include FX headwinds, China softness, and regulatory shifts in alcohol consumption. Competitive positioning against peers like Heineken remains key, with balanced monitoring of volume trends and margin expansion essential for sustained performance.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer. Disclaimers and Limitations
Be on the lookout for a price bounce soon.
BUD moved above its 50-day moving average on April 30, 2026 date and that indicates a change from a downward trend to an upward trend.
The 10-day moving average for BUD crossed bullishly above the 50-day moving average on April 30, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In of 14 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .
Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where BUD advanced for three days, in of 314 cases, the price rose further within the following month. The odds of a continued upward trend are .
The Aroon Indicator entered an Uptrend today. In of 243 cases where BUD Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .
The 10-day RSI Indicator for BUD moved out of overbought territory on May 28, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 29 similar instances where the indicator moved out of overbought territory. In of the 29 cases, the stock moved lower in the following days. This puts the odds of a move lower at .
The Momentum Indicator moved below the 0 level on May 29, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on BUD as a result. In of 75 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .
The Moving Average Convergence Divergence Histogram (MACD) for BUD turned negative on May 29, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 44 similar instances when the indicator turned negative. In of the 44 cases the stock turned lower in the days that followed. This puts the odds of success at .
Following a 3-day decline, the stock is projected to fall further. Considering past instances where BUD declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
BUD broke above its upper Bollinger Band on May 05, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Tickeron Valuation Rating for company is (best 1 - 100 worst), which means the company is slightly undervalued. The valuation of the company is based on a proprietary formula which takes into account a set of fundamentals and gives us an estimate of the price per share for the company. We then compare this estimate with the current price per share. As a result, this company is rated as undervalued in the industry. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.787) is normal, around the industry mean (2.188). P/E Ratio (22.321) is within average values for comparable stocks, (18.373). Projected Growth (PEG Ratio) (1.892) is also within normal values, averaging (2.689). BUD has a moderately low Dividend Yield (0.017) as compared to the industry average of (0.038). P/S Ratio (2.617) is also within normal values, averaging (1.602).
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. BUD’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. BUD’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 79, placing this stock better than average.
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
a holding company whose subsidiaries manufactures and distributes alcoholic and non-alcoholic beverages
Industry FoodMeatFishDairy